fluoxetine hcl

FDA Drug Profile — FLUOXETINE HCL

fluoxetine hcl is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including FLUOXETINE HCL. Available dosage form: tablet.

Drug Details

Generic Name
fluoxetine hcl
Brand Names
FLUOXETINE HCL
Application Number
ANDA212683
Sponsor
Strides Pharma Science Limited
NDC Codes
1
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
FLUOXETINE

Indications and Usage

Fluoxetine is indicated for the treatment of: Acute and maintenance treatment of Major Depressive Disorder [see CLINICAL STUDIES (14.1)] . Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD) [see CLINICAL STUDIES (14.2)] . Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa [see CLINICAL STUDIES (14.3)] . Acute treatment of Panic Disorder, with or without agoraphobia [see CLINICAL STUDIES (14.4)] . Fluoxetine and Olanzapine in Combination is indicated for the treatment of: Acute treatment of depressive episodes associated with Bipolar I Disorder. Treatment resistant depression (Major Depressive Disorder in patients, who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode). Fluoxetine monotherapy is not indicated for the treatment of depressive episodes associated with Bipolar I Disorder or the treatment of treatment resistant depression. When using fluoxetine and olanzapine in combination, also refer to the Clinical Studies section of the package insert for Symbyax ®.